Abstract
Tubulin is a potent molecular target for development of anticancer agents. In this report, the binding of non-steroidal anti-inflammatory drugs as tubulin inhibitors potential are investigated by extensive computational techniques, such as, molecular docking, molecular dynamics simulations and binding free energy calculations. The results suggest that a potent indomethacin derivative inhibits the tubulin polymerization by interacting on the colchicine-site binding. This potential chemotherapeutic agent showed high stability in the molecular dynamics simulations, when complexed on the same binding site of colchicine, a potent and toxic, tubulin inhibitor. Then, our results can be useful designing new compounds for cancer treatments.
Keywords: Tubulin, chemotherapeutic agents, indomethacin derivative, molecular docking, molecular dynamics, binding free energy.
Combinatorial Chemistry & High Throughput Screening
Title:A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents
Volume: 19 Issue: 6
Author(s): Kelly Miranda Costa, Cláudio Nahum Alves, José Rogério Araújo Silva and Jerônimo Lameira
Affiliation:
Keywords: Tubulin, chemotherapeutic agents, indomethacin derivative, molecular docking, molecular dynamics, binding free energy.
Abstract: Tubulin is a potent molecular target for development of anticancer agents. In this report, the binding of non-steroidal anti-inflammatory drugs as tubulin inhibitors potential are investigated by extensive computational techniques, such as, molecular docking, molecular dynamics simulations and binding free energy calculations. The results suggest that a potent indomethacin derivative inhibits the tubulin polymerization by interacting on the colchicine-site binding. This potential chemotherapeutic agent showed high stability in the molecular dynamics simulations, when complexed on the same binding site of colchicine, a potent and toxic, tubulin inhibitor. Then, our results can be useful designing new compounds for cancer treatments.
Export Options
About this article
Cite this article as:
Miranda Costa Kelly, Nahum Alves Cláudio, Rogério Araújo Silva José and Lameira Jerônimo, A Computational Analysis of Indomethacin Derivative as Tubulin Inhibitor: Insights into Development of Chemotherapeutic Agents, Combinatorial Chemistry & High Throughput Screening 2016; 19(6) . https://dx.doi.org/10.2174/1386207319666160504095838
DOI https://dx.doi.org/10.2174/1386207319666160504095838 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Role of Heat Shock Protein (HSP) in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Medicinal Chemistry Therapeutic DNA Delivery to Skeletal Muscle
Current Genomics Aptamers to Hemagglutinin: A Novel Tool for Influenza Virus Recognition and Neutralization
Current Pharmaceutical Design Modulation of Kinases by Small Molecules for Therapeutic Management of Various Diseases - Part I
Current Topics in Medicinal Chemistry From the Obscure and Mysterious Acute Phase Response to Toll-Like Receptors and the Cytokine Network
Current Immunology Reviews (Discontinued) Crimean-Congo Hemorrhagic Fever Virus
Current Molecular Medicine Novel Targets for Antiinflammatory and Antiarthritic Agents
Current Pharmaceutical Design Piper sarmentosum Roxb. Root Extracts Confer Neuroprotection by Attenuating Beta Amyloid-Induced Pro-Inflammatory Cytokines Released from Microglial Cells
Current Alzheimer Research Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2
Current Topics in Medicinal Chemistry Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
Current Pharmaceutical Design Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Current Medicinal Chemistry QSAR and Molecular Docking Directed Synthesis and Preliminary Evaluation of Novel Non-Nucleoside HCV NS5B Polymerase Inhibitors
Anti-Infective Agents Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Possibilities of Non-Viral Gene Transfer to Improve Cutaneous Wound Healing
Current Gene Therapy Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures
Current Medicinal Chemistry The Cytotoxic and Immunomodulatory Effects of Titanium Dioxide Nanoparticles and <i>Sargassum oligocystum</i> on <i>Toxoplasma gondii In Vitro</i> and <i>In Vivo</i>
Anti-Infective Agents Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends
Current Drug Safety Structural and Molecular Tear Film Changes in Glaucoma
Current Medicinal Chemistry